Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsJournal of clinical oncology, 2015-05, Vol.33 (14), p.1543-1550 [Peer Reviewed Journal]Published by the American Society of Clinical Oncology. ;Published by the American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.9093 ;PMID: 25823737Full text available |
|
2 |
Material Type: Article
|
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical CancerThe New England journal of medicine, 2018-11, Vol.379 (20), p.1895-1904 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1806395 ;PMID: 30380365Full text available |
|
3 |
Material Type: Article
|
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical CancerThe New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112435 ;PMID: 34534429Full text available |
|
4 |
Material Type: Article
|
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical CancerThe New England journal of medicine, 2018-11, Vol.379 (20), p.1905-1914 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804923 ;PMID: 30379613Full text available |
|
5 |
Material Type: Article
|
SUCCOR cone study: conization before radical hysterectomyInternational journal of gynecological cancer, 2022-02, Vol.32 (2), p.117-124 [Peer Reviewed Journal]IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-002544 ;PMID: 35039455Full text available |
|
6 |
Material Type: Article
|
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review StudyJournal of clinical oncology, 2020-04, Vol.38 (10), p.1030-1040 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03012 ;PMID: 32031867Full text available |
|
7 |
Material Type: Article
|
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 TrialJournal of clinical oncology, 2019-11, Vol.37 (31), p.2825-2834 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00739 ;PMID: 31487218Full text available |
|
8 |
Material Type: Article
|
N 6 -methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modificationCell death & disease, 2020-10, Vol.11 (10), p.911 [Peer Reviewed Journal]EISSN: 2041-4889 ;DOI: 10.1038/s41419-020-03071-y ;PMID: 33099572Full text available |
|
9 |
Material Type: Article
|
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II TrialJournal of clinical oncology, 2020-12, Vol.38 (34), p.4095-4106 [Peer Reviewed Journal]2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01920 ;PMID: 33052760Full text available |
|
10 |
Material Type: Article
|
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505Journal of clinical oncology, 2015-07, Vol.33 (19), p.2129-2135 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.4391 ;PMID: 25732161Full text available |
|
11 |
Material Type: Article
|
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 studyThe lancet oncology, 2021-05, Vol.22 (5), p.609-619 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00056-5 ;PMID: 33845034Full text available |
|
12 |
Material Type: Article
|
Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled TrialJournal of clinical oncology, 2021-11, Vol.39 (33), p.3682-3692 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.02530 ;PMID: 34506246Full text available |
|
13 |
Material Type: Article
|
Trends in cervical cancer incidence in sub-Saharan AfricaBritish journal of cancer, 2020-07, Vol.123 (1), p.148-154 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0831-9 ;PMID: 32336751Full text available |
|
14 |
Material Type: Article
|
Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II StudyJournal of clinical oncology, 2022-03, Vol.40 (7), p.762-771 [Peer Reviewed Journal]2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.02067 ;PMID: 34932394Full text available |
|
15 |
Material Type: Article
|
Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21Cancer biology & therapy, 2016-01, Vol.17 (1), p.104-113 [Peer Reviewed Journal]2016 © Taylor & Francis Group, LLC 2016 ;2016 © Taylor & Francis Group, LLC 2016 Taylor & Francis Group, LLC ;ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2015.1108496 ;PMID: 26574780Full text available |
|
16 |
Material Type: Article
|
Cytology versus HPV testing for cervical cancer screening in the general populationCochrane database of systematic reviews, 2017-08, Vol.2018 (7), p.CD008587 [Peer Reviewed Journal]Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD008587.pub2 ;PMID: 28796882Full text available |
|
17 |
Material Type: Article
|
Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysisThe lancet oncology, 2017-12, Vol.18 (12), p.1665-1679 [Peer Reviewed Journal]2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 1, 2017 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30700-3 ;PMID: 29126708Full text available |
|
18 |
Material Type: Article
|
Bilateral Negative Sentinel Nodes Accurately Predict Absence of Lymph Node Metastasis in Early Cervical Cancer: Results of the SENTICOL StudyJournal of clinical oncology, 2011-05, Vol.29 (13), p.1686-1691 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2010.32.0432 ;PMID: 21444878Full text available |
|
19 |
Material Type: Article
|
Relative Performance of HPV and Cytology Components of Cotesting in Cervical ScreeningJNCI : Journal of the National Cancer Institute, 2018-05, Vol.110 (5), p.501-508 [Peer Reviewed Journal]Published by Oxford University Press 2017. This work is written by US Government employees and is in the public domain in the US. 2017 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djx225 ;PMID: 29145648Full text available |
|
20 |
Material Type: Article
|
Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical OutcomeNeoplasia (New York, N.Y.), 2019-06, Vol.21 (6), p.591-601 [Peer Reviewed Journal]2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 1476-5586 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2019.04.003 ;PMID: 31055200Full text available |